Ibetin

Ibuprofen, the active ingredient in Ibetin, is a non‑steroidal anti‑inflammatory drug presented as an oral tablet for oral use. It treats mild to moderate pain, fever, and inflammatory conditions in adults and children as directed by a healthcare professional.

GNH USA supplies Ibetin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibetin (ibuprofen) is used to manage pain and inflammation associated with several common conditions.

- Mild to moderate pain: provides analgesic relief for headaches, dental pain, and musculoskeletal discomfort. - Fever: reduces elevated body temperature. - Osteoarthritis and rheumatoid arthritis: alleviates joint pain and swelling. - Dysmenorrhea: eases menstrual cramps. - Headache: relieves tension‑type and migraine‑associated pain.

Ibetin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache or dizziness. - Skin rash or mild itching. - Mild elevation of liver enzymes. - Transient increase in blood pressure.

Serious or Rare Side Effects: - Gastrointestinal bleeding, ulcer perforation, or hemorrhage. - Acute renal impairment or failure. - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. - Hepatic injury or hepatitis. - Cardiovascular events including myocardial infarction in high‑risk patients.

Before using Ibetin, consider the following safety measures.

- Assess renal function: avoid in severe renal impairment. - Monitor gastrointestinal risk: use with food in patients with ulcer history. - Check for hypersensitivity: do not use if allergic to ibuprofen or other NSAIDs. - Use caution during pregnancy: consult a healthcare provider, especially in the third trimester. - Avoid concomitant use with anticoagulants unless directed by a clinician. - Store at room temperature: keep in the original pack, protect from moisture and heat.

Ibetin can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may affect renal function, especially in dehydrated patients. - Methotrexate: reduced clearance can increase toxicity; monitor serum levels.